Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Sevion Therapeutics Inc.
DescriptionModified formulation of SNS01, a compound composed of a short interfering RNA (siRNA) against eukaryotic translation initiation factor 5A1 (eIF5A), an eIF5A plasmid and polyethyleneiminie (PEI)
Molecular Target Eukaryotic translation initiation factor 5A (eIF5A)
Mechanism of ActionGene silencing
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today